Invesco S&P SmallCap Health Care ETF (PSCH) Holdings
PSCH holdings summary
as of Oct 23, 2026- Holdings
- 70 positions listed
- Top 10 weight
- 34.1% of net assets
- Effective holdings
- 47 equal-weight equivalent
- Largest holding
- GKOS 5.22% Glaukos Corporation
- Annual turnover
- 29.3% of the portfolio traded
All PSCH holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | GKOS | Glaukos Corporation | Healthcare | 5.22% | $8.8M | $9.72B | — |
| 2 | PTGX | Protagonist Therapeutics, Inc. | Healthcare | 4.58% | $7.7M | $8.33B | 125.0 |
| 3 | ALKS | Alkermes plc | Healthcare | 3.93% | $6.6M | $6.92B | 108.5 |
| 4 | TGTX | TG Therapeutics, Inc. | Healthcare | 3.89% | $6.5M | $8.26B | 19.6 |
| 5 | LGND | Ligand Pharmaceuticals Incorporated | Healthcare | 3.29% | $5.5M | $5.89B | 31.1 |
| 6 | TFX | Teleflex Incorporated | Healthcare | 2.80% | $4.7M | $5.53B | — |
| 7 | PTCT | PTC Therapeutics, Inc. | Healthcare | 2.74% | $4.6M | $4.94B | — |
| 8 | MMSI | Merit Medical Systems, Inc. | Healthcare | 2.74% | $4.6M | $5.33B | 36.7 |
| 9 | RDNT | RadNet, Inc. | Healthcare | 2.55% | $4.3M | $5.41B | — |
| 10 | CON | Concentra Group Holdings Parent, Inc. | Healthcare | 2.41% | $4.1M | $4.91B | 24.9 |
| 11 | ITGR | Integer Holdings Corporation | Healthcare | 2.24% | $3.8M | $4.31B | 34.6 |
| 12 | ICUI | ICU Medical, Inc. | Healthcare | 2.20% | $3.7M | $4.08B | 137.0 |
| 13 | INDV | Indivior PLC | Healthcare | 2.10% | $3.5M | $3.83B | 11.6 |
| 14 | VCYT | Veracyte, Inc. | Healthcare | 1.92% | $3.2M | $3.47B | 30.8 |
| 15 | ARQT | Arcutis Biotherapeutics, Inc. | Healthcare | 1.92% | $3.2M | $3.62B | 131.0 |
| 16 | OGN | Organon & Co. | Healthcare | 1.83% | $3.1M | $3.61B | 17.6 |
| 17 | AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | 1.83% | $3.1M | $6.68B | 39.1 |
| 18 | LFST | LifeStance Health Group, Inc. | Healthcare | 1.81% | $3.1M | $4.46B | 90.3 |
| 19 | WAY | Waystar Holding Corp. | Healthcare | 1.80% | $3.0M | $5.25B | 39.1 |
| 20 | NHC | National HealthCare Corporation | Healthcare | 1.67% | $2.8M | $3.80B | 27.0 |
| 21 | ATRC | AtriCure, Inc. | Healthcare | 1.56% | $2.6M | $2.85B | 267.0 |
| 22 | PRVA | Privia Health Group, Inc. | Healthcare | 1.56% | $2.6M | $2.88B | 107.2 |
| 23 | ACHC | Acadia Healthcare Company, Inc. | Healthcare | 1.49% | $2.5M | $2.79B | — |
| 24 | LQDA | Liquidia Corporation | Healthcare | 1.42% | $2.4M | $3.07B | 24.7 |
| 25 | TMDX | TransMedics Group, Inc. | Healthcare | 1.41% | $2.4M | $2.45B | 18.3 |
| 26 | ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | 1.39% | $2.3M | $3.29B | 8.6 |
| 27 | ADMA | ADMA Biologics, Inc. | Healthcare | 1.38% | $2.3M | $2.39B | 15.3 |
| 28 | NEOG | Neogen Corporation | Healthcare | 1.37% | $2.3M | $2.58B | — |
| 29 | SUPN | Supernus Pharmaceuticals, Inc. | Healthcare | 1.31% | $2.2M | $2.21B | — |
| 30 | PBH | Prestige Consumer Healthcare Inc. | Healthcare | 1.28% | $2.2M | $2.36B | 14.0 |
| 31 | CRVL | CorVel Corporation | Financial Services | 1.27% | $2.1M | $4.03B | 35.6 |
| 32 | PGNY | Progyny, Inc. | Healthcare | 1.18% | $2.0M | $2.06B | 29.2 |
| 33 | PRGO | Perrigo Company plc | Healthcare | 1.17% | $2.0M | $2.30B | — |
| 34 | ADUS | Addus HomeCare Corporation | Healthcare | 1.16% | $2.0M | $2.17B | 20.3 |
| 35 | UFPT | UFP Technologies, Inc. | Healthcare | 1.16% | $1.9M | $2.26B | 31.5 |
| 36 | MD | Pediatrix Medical Group, Inc. | Healthcare | 1.13% | $1.9M | $2.22B | 13.1 |
| 37 | RCUS | Arcus Biosciences, Inc. | Healthcare | 1.12% | $1.9M | $2.82B | — |
| 38 | VCEL | Vericel Corporation | Healthcare | 1.11% | $1.9M | $2.05B | 85.4 |
| 39 | FTRE | Fortrea Holdings Inc. | Healthcare | 1.11% | $1.9M | $2.14B | — |
| 40 | SRPT | Sarepta Therapeutics, Inc. | Healthcare | 1.08% | $1.8M | $1.81B | — |
| 41 | NEO | NeoGenomics, Inc. | Healthcare | 1.08% | $1.8M | $2.14B | — |
| 42 | INSP | Inspire Medical Systems, Inc. | Healthcare | 1.04% | $1.7M | $1.99B | 15.2 |
| 43 | HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | 1.03% | $1.7M | $2.21B | 12.2 |
| 44 | LMAT | LeMaitre Vascular, Inc. | Healthcare | 0.96% | $1.6M | $1.85B | 28.4 |
| 45 | XNCR | Xencor, Inc. | Healthcare | 0.92% | $1.5M | $1.70B | — |
| 46 | OMCL | Omnicell, Inc. | Healthcare | 0.90% | $1.5M | $1.61B | 42.1 |
| 47 | ASTH | Astrana Health, Inc. | Healthcare | 0.87% | $1.5M | $1.83B | 44.3 |
| 48 | ALHC | Alignment Healthcare, Inc. | Healthcare | 0.83% | $1.4M | $1.72B | 43.6 |
| 49 | AMN | AMN Healthcare Services, Inc. | Healthcare | 0.83% | $1.4M | $1.57B | 15.1 |
| 50 | INVA | Innoviva, Inc. | Healthcare | 0.82% | $1.4M | $1.50B | 4.9 |
| 51 | PCRX | Pacira BioSciences, Inc. | Healthcare | 0.80% | $1.3M | $1.45B | 103.8 |
| 52 | AZTA | Azenta, Inc. | Healthcare | 0.77% | $1.3M | $1.49B | — |
| 53 | CNMD | CONMED Corporation | Healthcare | 0.76% | $1.3M | $1.40B | 25.3 |
| 54 | ANIP | ANI Pharmaceuticals, Inc. | Healthcare | 0.75% | $1.3M | $1.66B | 15.6 |
| 55 | VIR | Vir Biotechnology, Inc. | Healthcare | 0.74% | $1.2M | $1.69B | — |
| 56 | USPH | U.S. Physical Therapy, Inc. | Healthcare | 0.70% | $1.2M | $1.28B | 476.2 |
| 57 | SDGR | Schrödinger, Inc. | Healthcare | 0.67% | $1.1M | $1.69B | — |
| 58 | TNDM | Tandem Diabetes Care, Inc. | Healthcare | 0.61% | $1.0M | $1.13B | — |
| 59 | ENOV | Enovis Corporation | Healthcare | 0.61% | $1.0M | $1.13B | — |
| 60 | AORT | Artivion, Inc. | Healthcare | 0.60% | $1.0M | $1.06B | — |
| 61 | CERT | Certara, Inc. | Healthcare | 0.59% | $999,795.23 | $1.43B | — |
| 62 | QDEL | QuidelOrtho Corporation | Healthcare | 0.53% | $890,650.21 | $885.3M | — |
| 63 | IART | Integra LifeSciences Holdings Corporation | Healthcare | 0.48% | $805,385.93 | $1.03B | — |
| 64 | HSTM | HealthStream, Inc. | Healthcare | 0.42% | $713,899.20 | $1.01B | 46.0 |
| 65 | PAHC | Phibro Animal Health Corporation | Healthcare | 0.41% | $697,249.96 | $1.58B | 16.0 |
| 66 | AMPH | Amphastar Pharmaceuticals, Inc. | Healthcare | 0.41% | $696,745.44 | $1.10B | 15.3 |
| 67 | COLL | Collegium Pharmaceutical, Inc. | Healthcare | 0.40% | $664,624.18 | $755.0M | 18.3 |
| 68 | STAA | STAAR Surgical Company | Healthcare | 0.36% | $603,913.32 | $1.07B | 265.9 |
| 69 | AHCO | AdaptHealth Corp. | Healthcare | 0.33% | $549,761.24 | $803.1M | — |
| 70 | AGPXX | Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional | Other | 0.01% | $12,613.06 | — | — |
Weights as a percentage of net assets. Value held = weight × net assets ($168.2M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
PSCH sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 98.1% | 68 | GKOS, PTGX, ALKS |
| Financial Services | 1.3% | 1 | CRVL |
| Other | 0.0% | 1 | AGPXX |
Sum of the weights of the holdings in each sector.
PSCH top industries
PSCH overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| IWM | iShares Russell 2000 ETF | 6.2% | 67 of 1,962 | 0.19% |
| VTI | Vanguard Total Stock Market ETF | 0.2% | 69 of 2,941 | 0.03% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 3 of 8,035 | 0.05% |
| SPY | SPDR S&P 500 ETF | 0.0% | 0 of 502 | 0.09% |
| QQQ | Invesco QQQ ETF | 0.0% | 0 of 101 | 0.17% |
| DIA | SPDR Dow Jones Industrial Average ETF | 0.0% | 0 of 30 | 0.16% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the PSCH portfolio
Invesco S&P SmallCap Health Care ETF holds 70 positions. The ten largest make up 34.1% of the fund and the top 50 88.4%, so it behaves like a portfolio of about 47 equally weighted stocks. The biggest positions are Glaukos Corporation (5.22%), Protagonist Therapeutics, Inc. (4.58%), Alkermes plc (3.93%), TG Therapeutics, Inc. (3.89%), Ligand Pharmaceuticals Incorporated (3.29%).
By sector, Healthcare is 98.1%, Financial Services is 1.3%, Other is 0.0%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 23, 2026; positions change as the fund rebalances.
Related: PSCH chart, PSCH performance, PSCH dividends, PSCH overview.
PSCH holdings FAQ
How many holdings does PSCH have?
PSCH holds 70 positions as of October 23, 2026.
What are the top 10 holdings of PSCH?
The ten largest holdings are Glaukos Corporation (5.22%), Protagonist Therapeutics, Inc. (4.58%), Alkermes plc (3.93%), TG Therapeutics, Inc. (3.89%), Ligand Pharmaceuticals Incorporated (3.29%), Teleflex Incorporated (2.80%), PTC Therapeutics, Inc. (2.74%), Merit Medical Systems, Inc. (2.74%), RadNet, Inc. (2.55%), Concentra Group Holdings Parent, Inc. (2.41%). Together they are 34.1% of the fund.
What percentage of PSCH is Glaukos Corporation?
Glaukos Corporation is the largest holding at 5.22% of net assets, about $8.8M of the fund's $168.2M.
Which sector is the largest in PSCH?
Healthcare is the largest sector at 98.1%, followed by Financial Services (1.3%) and Other (0.0%), based on the sectors of the individual holdings.
How concentrated is PSCH?
The top 10 holdings are 34.1% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) PSCH behaves like a portfolio of about 47 equally weighted stocks.